Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tg Therapeutics (TGTX) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Tg Therapeutics (TGTX) over the last 10 years, with Q3 2025 value amounting to 0.15%.

  • Tg Therapeutics' Return on Capital Employed rose 1500.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year increase of 1500.0%. This contributed to the annual value of 0.12% for FY2024, which is 200.0% up from last year.
  • Per Tg Therapeutics' latest filing, its Return on Capital Employed stood at 0.15% for Q3 2025, which was up 1500.0% from 0.17% recorded in Q2 2025.
  • Over the past 5 years, Tg Therapeutics' Return on Capital Employed peaked at 0.37% during Q2 2024, and registered a low of 1.43% during Q4 2022.
  • Over the past 5 years, Tg Therapeutics' median Return on Capital Employed value was 0.63% (recorded in 2021), while the average stood at 0.54%.
  • In the last 5 years, Tg Therapeutics' Return on Capital Employed skyrocketed by 20300bps in 2021 and then crashed by -4900bps in 2022.
  • Quarter analysis of 5 years shows Tg Therapeutics' Return on Capital Employed stood at 1.05% in 2021, then crashed by -37bps to 1.43% in 2022, then skyrocketed by 105bps to 0.07% in 2023, then increased by 14bps to 0.09% in 2024, then skyrocketed by 70bps to 0.15% in 2025.
  • Its Return on Capital Employed was 0.15% in Q3 2025, compared to 0.17% in Q2 2025 and 0.13% in Q1 2025.